tiprankstipranks
Trending News
More News >
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market
Advertisement

PharmaCyte Biotech (PMCB) Technical Analysis

Compare
233 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
PharmaCyte Biotech’s (PMCB) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting PharmaCyte Biotech is a Sell.
PharmaCyte Biotech’s (PMCB) 20-Day exponential moving average is 0.99, while PharmaCyte Biotech’s (PMCB) share price is $1.04, making it a Buy.
PharmaCyte Biotech’s (PMCB) 50-Day exponential moving average is 1.00, while PharmaCyte Biotech’s (PMCB) share price is $1.04, making it a Buy.

PharmaCyte Biotech (PMCB) Pivot Points

Sep 16, 2025, 07:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.93
0.96
1.00
1.03
1.07
1.10
1.14
Fibonacci
0.96
0.99
1.01
1.03
1.06
1.08
1.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PharmaCyte Biotech (PMCB) Moving Averages

Sep 16, 2025, 07:17 AM
Period
Simple
Exponential
MA5
1.06Sell
1.03Buy
MA10
1.00Buy
1.01Buy
MA20
0.99Buy
0.99Buy
MA50
0.99Buy
1.00Buy
MA100
1.04Sell
1.08Sell
MA200
1.31Sell
1.30Sell
PharmaCyte Biotech’s (PMCB) 10-Day exponential moving average is 1.01, while PharmaCyte Biotech’s (PMCB) share price is $1.04, making it a Buy.
PharmaCyte Biotech’s (PMCB) 100-Day exponential moving average is 1.08, while PharmaCyte Biotech’s (PMCB) share price is $1.04, making it a Sell.
PharmaCyte Biotech’s (PMCB) stock price is $1.04 and PharmaCyte Biotech’s (PMCB) 50-day simple moving average is 0.99, creating a Buy signal.
PharmaCyte Biotech’s (PMCB) stock price is $1.04 and PharmaCyte Biotech’s (PMCB) 100-day simple moving average is 1.04, creating a Sell signal.
PharmaCyte Biotech’s (PMCB) stock price is $1.04 and PharmaCyte Biotech’s (PMCB) 200-day simple moving average is 1.31, creating a Sell signal.

PharmaCyte Biotech (PMCB) Technical Indicators

Sep 16, 2025, 07:17 AM
Name
Value
Implied Action
RSI (14)
55.18
Neutral
STOCH (9,6)
31.51
Neutral
STOCHRSI (14)
31.93
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
29.85
Neutral
Williams %R
-64.44
Buy
CCI (14)
86.31
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
38.38
Neutral
ROC
7.22
Buy
PharmaCyte Biotech’s (PMCB) Relative Strength Index (RSI) is 55.18, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Trend Strength Indicator (ADX) is 29.85, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Commodity Channel Index (CCI) is 86.31, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Price Rate of Change (ROC) is 7.22, creating a Buy signal.

FAQ

Is PMCB a Buy, Hold, or Sell?
Based on PMCB’s technical indicators, PMCB is a Buy.
    What is PMCB’s RSI (14)?
    PMCB’s RSI (14) is 55.18, which suggests PMCB is a Neutral.
      What is PMCB’s MACD?
      PMCB’s MACD is 0.02, which suggests PMCB is a Sell.
        What is PMCB’s 5-day moving average?
        PMCB’s 5-day moving average is 1.06, which suggests PMCB is a Sell.
          What is PMCB’s 20-day moving average?
          PMCB 20-day moving average is 0.99, which suggests PMCB is a Buy.
            What is PMCB’s 50-day moving average?
            PMCB’s 50-day moving average is 0.99, which suggests PMCB is a Buy.
              What is PMCB’s 200-day moving average?
              PMCB’s 200-day moving average is 1.31, which suggests PMCB is a Sell.
                What is PMCB’s Williams % R (14)?
                PMCB’s Williams % R (14) is -64.44, which suggests PMCB is a Buy.
                  What is PMCB’s CCI (14)?
                  PMCB’s CCI (14) is 86.31, which suggests PMCB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis